Cabaletta Bio (CABA) Research & Development (2018 - 2026)
Cabaletta Bio (CABA) reported Research & Development of $44.43 million for Q2 2026, up 18.0% from $37.64 million a year earlier.
Powered by 
Analysis
Cabaletta Bio (CABA) Research & Development (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cabaletta Bio's Research & Development came in at $158.09 million, up 33.4% year-over-year; for FY2025, it was $142.67 million, up 46.8% from FY2024.
- Research & Development has increased for seven consecutive years, with a five-year compound annual growth rate of 46.2% (FY2020 to FY2025).
- By year, Research & Development came in at $97.2 million in FY2024 (+75.4%), $55.42 million in FY2023 (+41.0%), $39.3 million in FY2022 (+20.9%) and $32.49 million in FY2021 (+52.0%).
- The Q2 2026 figure ranks as the highest quarterly Research & Development in data going back to Q3 2018.
- Over the past five years, the year-over-year growth in Research & Development ranged from 0.6% (Q3 2022) to 98.6% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Cabaletta Bio | 339.09 Mn | 339.09 Mn | - | 44.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.43 Mn |
| Dec 31, 2025 | 36.19 Mn |
| Sep 30, 2025 | 39.82 Mn |
| Jun 30, 2025 | 37.64 Mn |
| Mar 31, 2025 | 29.02 Mn |
| Dec 31, 2024 | 25.53 Mn |
| Sep 30, 2024 | 26.29 Mn |
| Jun 30, 2024 | 23.43 Mn |
| Mar 31, 2024 | 21.95 Mn |
| Dec 31, 2023 | 17.41 Mn |
| Sep 30, 2023 | 13.79 Mn |
| Jun 30, 2023 | 11.80 Mn |
| Mar 31, 2023 | 12.44 Mn |
| Dec 31, 2022 | 12.40 Mn |
| Sep 30, 2022 | 8.22 Mn |
| Jun 30, 2022 | 9.51 Mn |
| Mar 31, 2022 | 9.17 Mn |
| Dec 31, 2021 | 9.92 Mn |
| Sep 30, 2021 | 8.17 Mn |
| Jun 30, 2021 | 7.85 Mn |
API Access
Cabaletta Bio Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CABA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CABA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CABA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();